Download PDF › Poster presentation at 39th Annual Symposium of the National Neurotrauma Society ATLANTA, Ga., June 27, 2022 – NeuroTrauma Sciences, LLC (NTS), a private biopharmaceutical company developing... read more →
NTS-105 Decreases Cell Death After In Vitro Stretch Injury NeuroTrauma Sciences reported data on its novel neuroactive small molecule NTS-105 in a poster presentation at the 39th Annual... read more →